|
TRIM23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.330200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.356400E-03 |
| Normal-vs-Stage2 |
9.354200E-01 |
| Normal-vs-Stage3 |
4.394600E-01 |
| Normal-vs-Stage4 |
8.390000E-01 |
| Stage1-vs-Stage2 |
2.026400E-01 |
| Stage1-vs-Stage3 |
5.735900E-02 |
| Stage1-vs-Stage4 |
4.368400E-01 |
| Stage2-vs-Stage3 |
4.690800E-01 |
| Stage2-vs-Stage4 |
8.791800E-01 |
| Stage3-vs-Stage4 |
5.492600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.841800E-02 |
| Normal-vs-AfricanAmerican |
2.635600E-01 |
| Normal-vs-Asian |
8.639200E-01 |
| Caucasian-vs-AfricanAmerican |
9.921800E-01 |
| Caucasian-vs-Asian |
5.365400E-01 |
| AfricanAmerican-vs-Asian |
5.845000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.458800E-03 |
| Normal-vs-Female |
2.117400E-01 |
| Male-vs-Female |
1.521080E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.549800E-01 |
| Normal-vs-Extreme_Weight |
6.227700E-04 |
| Normal-vs-Obese |
9.706000E-01 |
| Normal-vs-Extreme_Obese |
4.099400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.895750E-01 |
| Normal_Weight-vs-Obese |
5.697200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.157400E-01 |
| Extreme_Weight-vs-Obese |
1.056420E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.642200E-01 |
| Obese-vs-Extreme_Obese |
5.079600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.369800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.527600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.704300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.431200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.347000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.864800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.570800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.029730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.129200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.333200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.974000E-04 |
| Normal-VS-Type2 PRCC |
3.279200E-01 |
| Normal-VS-KIRP CIMP |
3.420000E-01 |
| Normal-VS-Unclassified PRCC |
4.972000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.157100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.179600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.096200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.017200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.952800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.853000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.810200E-01 |
| Normal-vs-N1 |
5.565200E-01 |
| Normal-vs-N2 |
4.183800E-01 |
| N0-vs-N1 |
2.796600E-01 |
| N0-vs-N2 |
2.404600E-01 |
| N1-vs-N2 |
5.537800E-01 |
|
|
